replicating vesicular stomatitis virus vector-based vaccine (University of Western Ontario)

N/A

Report date: 2025/01/26 16:51:40

Base Information

Drug Namereplicating vesicular stomatitis virus vector-based vaccine (University of Western Ontario)
Drug Alias NameVSV vector-based vaccine targeting spike glycoprotein (University of Western Ontario)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Western Ontario
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Western Ontario
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A